pcDNA3-sACE2(WT)-sfGFP Citations (5)

Originally described in: Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, Herbert AS, Procko E Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4. PubMed Journal

---

Articles Citing pcDNA3-sACE2(WT)-sfGFP

Articles
The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2. Procko E. bioRxiv. 2020 May 11. doi: 10.1101/2020.03.16.994236. PubMed
Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins. Bouwman KM, Tomris I, Turner HL, van der Woude R, Shamorkina TM, Bosman GP, Rockx B, Herfst S, Snijder J, Haagmans BL, Ward AB, Boons GJ, de Vries RP. PLoS Pathog. 2021 Feb 8;17(2):e1009282. doi: 10.1371/journal.ppat.1009282. eCollection 2021 Feb. PubMed
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai JP, Zhou R, Chan KH, Zhao H, Zhu L, Siu KL, Fung SY, Yung S, Chan TM, To KK, Chan JF, Cai Z, Lau SKP, Chen Z, Jin DY, Woo PCY, Yuen KY. Cell. 2021 Apr 15;184(8):2212-2228.e12. doi: 10.1016/j.cell.2021.02.053. Epub 2021 Mar 2. PubMed
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Yang TJ, Yu PY, Chang YC, Liang KH, Tso HC, Ho MR, Chen WY, Lin HT, Wu HC, Hsu SD. Nat Struct Mol Biol. 2021 Sep;28(9):731-739. doi: 10.1038/s41594-021-00652-z. Epub 2021 Aug 12. PubMed
A rapid bead-based assay for screening of SARS-CoV-2 neutralizing antibodies. Lupitha SS, Darvin P, Chandrasekharan A, Varadarajan SN, Divakaran SJ, Easwaran S, Nelson-Sathi S, Umasankar PK, Jones S, Joseph I, Pillai MR, Santhoshkumar TR. Antib Ther. 2022 Mar 17;5(2):100-110. doi: 10.1093/abt/tbac007. eCollection 2022 Apr. PubMed

If you have published an article using this material, please email us at to have your article added to this page.